127 related articles for article (PubMed ID: 3610048)
1. The effect of recombinant alpha-interferon treatment on serum levels of hepatitis B virus-encoded proteins in man.
Hess G; Gerlich W; Gerken G; Manns M; Hütteroth TH; Meyer zum Büschenfelde KH
Hepatology; 1987; 7(4):704-8. PubMed ID: 3610048
[TBL] [Abstract][Full Text] [Related]
2. Changes in serum levels of hepatitis B virus markers after interferon treatment.
Ikeda H; Matsuura K; Tsuji T
Gastroenterol Jpn; 1989 Dec; 24(6):646-54. PubMed ID: 2481599
[TBL] [Abstract][Full Text] [Related]
3. Detection of proteins encoded by the pre-S region of hepatitis B virus in the sera of HBsAg carriers: relation to viral replication.
Ibarra MZ; Mora I; Bartolomé J; Porres JC; Carreño V
Liver; 1989 Jun; 9(3):153-8. PubMed ID: 2747440
[TBL] [Abstract][Full Text] [Related]
4. Virus-associated receptors for polymerized human serum albumin (RpHSA) in patients with chronic active hepatitis B treated with recombinant leukocyte A interferon.
Gerken G; Manns M; Hess G; Meyer zum Büschenfelde KH
Digestion; 1987; 37(2):96-102. PubMed ID: 3040500
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
6. Long-term remission of chronic hepatitis B after alpha-interferon therapy.
Korenman J; Baker B; Waggoner J; Everhart JE; Di Bisceglie AM; Hoofnagle JH
Ann Intern Med; 1991 Apr; 114(8):629-34. PubMed ID: 2003708
[TBL] [Abstract][Full Text] [Related]
7. Recombinant leukocyte interferon treatment of chronic hepatitis B.
Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous disappearance of viral replication and liver cell inflammation in HBsAg-positive chronic active hepatitis: results of a placebo vs. interferon trial.
Schalm SW; Heijtink RA
Hepatology; 1982; 2(6):791-4. PubMed ID: 7141389
[TBL] [Abstract][Full Text] [Related]
9. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection.
Alexander GJ; Brahm J; Fagan EA; Smith HM; Daniels HM; Eddleston AL; Williams R
Lancet; 1987 Jul; 2(8550):66-9. PubMed ID: 2885573
[TBL] [Abstract][Full Text] [Related]
10. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant leucocyte alpha-A interferon.
Hess G; Gerlich W; Slusarczyk J; Hütteroth TH; Meyer zum Büschenfelde KH
J Hepatol; 1986; 3 Suppl 2():S245-51. PubMed ID: 3598157
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
[TBL] [Abstract][Full Text] [Related]
14. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir.
Reijnders JG; Rijckborst V; Sonneveld MJ; Scherbeijn SM; Boucher CA; Hansen BE; Janssen HL
J Hepatol; 2011 Mar; 54(3):449-54. PubMed ID: 21112655
[TBL] [Abstract][Full Text] [Related]
16. Experimental HBsAg/anti-HBs complex assay for prediction of HBeAg loss in chronic hepatitis B patients treated with pegylated interferon and adefovir.
de Niet A; Jansen L; Zaaijer HL; Klause U; Takkenberg B; Janssen HL; Chu T; Petric R; Reesink HW
Antivir Ther; 2014; 19(3):259-67. PubMed ID: 24256626
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
18. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of a low dosage of human leukocyte interferon on chronic hepatitis B virus infection.
Matsumura N; Yoshikawa T; Kondo M; Kawakami H; Kishida T
Digestion; 1983; 26(4):205-12. PubMed ID: 6873506
[TBL] [Abstract][Full Text] [Related]
20. Albumin receptors on HBsAG particles and subsequent sero-conversion designate HBeAG-positive patients among chronic active liver disease patients.
Tsuji T
Acta Med Okayama; 1984 Feb; 38(1):89-92. PubMed ID: 6322527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]